Brie Carter - Author on Grafa

MAIA-BIOTECH-2026-CLINICAL-OUTLOOK

Corporación América Airports (NYSE:CAAP) reported robust passenger growth for 2025, fueled by a surge in international travel and record-breaking performances in key markets.

Eli Lilly (NYSE:LLY) shares gained after the U.S. Food and Drug Administration granted Breakthrough Therapy designation to its experimental antibody-drug conjugate, potentially accelerating the path to market for a treatment targeting hard-to-treat gynecologic cancers.

Netflix (NYSE:WBD) and Warner Bros. Discovery (NYSE:WBD) amended their definitive merger agreement on Tuesday, pivoting to an all-cash transaction to provide shareholders with greater price protection and accelerate the closing timeline.

Moderna (NASDAQ:MRNA) and Merck (NYSE:MRK) announced Tuesday that their individualized neoantigen therapy continues to show dramatic long-term benefits, providing the strongest evidence to date that mRNA technology can be harnessed to treat established cancer.

U.S. President Donald Trump has escalated his confrontation with European leaders on the eve of the World Economic Forum in Davos, threatening to impose a 200% tariff on French wine and champagne.

Murphy Oil (NYSE:MUR) announced today that its Civette-1X exploration well offshore Côte d’Ivoire reached total depth but failed to meet commercial thresholds, a result that provides a sober look at the frontier basin even as it confirms a working petroleum system.

Blockspace Media is expanding its Bitcoin analytics by acquiring Bitcoin Layers and launching a new data dashboard.

Magic Eden’s Jack Lu says rising prediction markets signal a new speculation supercycle for crypto and digital assets.

Cambium Bio (ASX:CMB), a clinical-stage regenerative medicine company specialising in ophthalmology and tissue repair, has secured a $2.4 million strategic investment from its major shareholder, Zheng Yang Biomedical Technology.